Stay updated on Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov error page footer shows revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header, replacing the previous study content and study record details.SummaryDifference19%

- Check55 days agoChange DetectedRevision: v3.6.6 appears in the page footer, replacing the old Revision: v3.6.5. This update marks a new build/version of the page rather than a change to study content.SummaryDifference0.1%

- Check76 days agoChange DetectedA newer revision label appears, updating from 'Revision: v3.6.4' to 'Revision: v3.6.5'. This reflects an updated build of the page.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page’s revision has been updated from v3.6.3 to v3.6.4, signaling a maintenance release to the ClinicalTrials.gov entry rather than a modification to trial content.SummaryDifference0.0%

Stay in the know with updates to Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.